828834554	828834554	CD	B-NP	O
|	|	NN	I-NP	O
PNMC	PNMC	NN	I-NP	O
|	|	NN	I-NP	O
69046457	69046457	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
282740	282740	CD	B-NP	O
|	|	CC	I-NP	O
2/20/2000	2/20/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ABDOMINAL	ABDOMINAL	NNP	I-NP	I-protein
PAIN	PAIN	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/20/2000	2/20/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/21/2001	1/21/2001	CD	B-NP	O
CHIEF	CHIEF	NN	I-NP	O
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
29-year-old	29-year-old	JJ	I-NP	O
G	G	NN	I-NP	O
3	3	CD	I-NP	O
P	P	NN	I-NP	O
2	2	CD	B-NP	O
admitted	admit	VBN	B-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	SYM	O	O
19	19	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
STAT	STAT	NN	I-NP	B-protein
cesarean	cesarean	JJ	I-NP	O
section	section	NN	I-NP	O
at	at	IN	B-PP	O
29	29	CD	B-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
fetal	fetal	JJ	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
following	follow	VBG	B-PP	O
laparoscopic	laparoscopic	JJ	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
readmitted	readmitte	VBN	I-VP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
1989	1989	CD	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
immunosuppressants	immunosuppressant	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
laparoscopic	laparoscopic	JJ	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
nineteen	nineteen	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Fetal	Fetal	JJ	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
developed	develop	VBD	B-VP	O
immediately	immediately	RB	I-VP	O
following	follow	VBG	I-VP	O
the	the	DT	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
STAT	STAT	NN	I-NP	B-protein
cesarean	cesarean	JJ	I-NP	O
section	section	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
3/3	3/3	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MFM	MFM	NN	I-NP	O
practice	practice	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
wound	wound	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
and	and	CC	I-VP	O
drained	drain	VBD	I-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
,	,	,	I-NP	O
healthy	healthy	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
identified	identify	VBN	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
b.i.d.	b.i.d.	VBN	I-VP	O
dressing	dress	VBG	I-VP	O
changes	change	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
visiting	visit	VBG	I-NP	O
nurse	nurse	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
to	to	TO	B-PP	O
100.0	100.0	CD	B-NP	O
,	,	,	O	O
slightly	slightly	RB	B-NP	O
foul-smelling	foul-smelling	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
surgery	surgery	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
worsening	worsen	VBG	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
swollen	swell	VBN	I-VP	O
and	and	CC	O	O
erythematous	erythematous	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Viral	Viral	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
transplant	transplant	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.4-1	1.4-1	CD	B-NP	O
.8	.8	NN	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
group	group	NN	B-NP	O
A	A	NN	I-NP	O
Strep	Strep	NN	I-NP	O
sepsis	sepsis	NN	I-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Cesarean	Cesarean	JJ	B-NP	B-protein
section	section	NN	I-NP	I-protein
x	x	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
and	and	CC	I-NP	O
2001	2001	CD	I-NP	O
,	,	,	O	O
laparoscopic	laparoscopic	JJ	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
on	on	IN	B-PP	O
10/24	10/24	CD	B-NP	O
,	,	,	O	O
D	D	NNP	B-NP	O
&	&	CC	I-NP	O
E	E	NNP	I-NP	O
for	for	IN	B-PP	O
SAb	SAb	NNP	B-NP	B-protein
in	in	IN	B-PP	O
11	11	CD	B-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
eye	eye	NN	I-NP	O
surgery	surgery	NN	I-NP	O
in	in	IN	B-PP	O
1973	1973	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Imuran	Imuran	NN	B-NP	O
75	75	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
cyclosporin	cyclosporin	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
pravastatin	pravastatin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
;	;	:	O	O
quinidine	quinidine	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Kaopectate	Kaopectate	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
i.d.	i.d.	JJ	I-NP	O
;	;	:	O	O
Zantac	Zantac	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
miconazole	miconazole	NN	B-NP	O
topical	topical	JJ	I-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
;	;	:	O	O
Tylenol	Tylenol	NN	B-NP	B-protein
#	#	#	I-NP	I-protein
3	3	CD	I-NP	I-protein
1-2	1-2	CD	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
4-6h	4-6h	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Sulfa	Sulfa	NN	B-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
IVP	IVP	NN	B-NP	O
dye	dye	NN	I-NP	O
all	all	DT	B-NP	O
cause	cause	VBP	B-VP	O
pink	pink	JJ	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
succinylcholine	succinylcholine	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.6	98.6	CD	I-NP	I-protein
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
120/60	120/60	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
18	18	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
74	74	CD	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
incision	incision	NN	I-NP	O
was	be	VBD	B-VP	O
open	open	JJ	B-ADJP	O
at	at	IN	B-PP	O
two	two	CD	B-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
gray	gray	JJ	B-NP	O
,	,	,	I-NP	O
malodorous	malodorous	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
draining	drain	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wound	wound	NN	I-NP	O
tracked	track	VBN	B-VP	O
superiorly	superiorly	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
fascia	fascia	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
necrotic	necrotic	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Distal	Distal	JJ	B-NP	O
extremities	extremity	NNS	I-NP	O
had	have	VBD	B-VP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-SBAR	O
left	leave	VBN	B-VP	O
with	with	IN	B-PP	O
erythema	erythema	NN	B-NP	O
and	and	CC	I-NP	O
tenderness	tenderness	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
dorsal	dorsal	JJ	I-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Wound	Wound	NN	I-NP	O
infection	infection	NN	I-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
for	for	IN	B-PP	O
immediate	immediate	JJ	B-NP	O
intraoperative	intraoperative	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	I-NP	O
wound	wound	NN	I-NP	O
debridement	debridement	NN	I-NP	O
.	.	.	O	O

Surgery	Surgery	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
intraoperatively	intraoperatively	RB	B-ADVP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
healthy	healthy	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
necrosis	necrosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	O	O
clindamycin	clindamycin	NN	B-NP	O
IV	IV	CD	I-NP	O
and	and	CC	O	O
t.i.d.	t.i.d.	RB	B-VP	O
dressing	dress	VBG	I-VP	O
changes	change	NNS	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
bacteremia	bacteremia	NN	B-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
Strep	Strep	NN	B-NP	O
and	and	CC	I-NP	O
diphtheroids	diphtheroid	NNS	I-NP	O
with	with	IN	B-PP	O
obvious	obvious	JJ	B-NP	O
polymicrobial	polymicrobial	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
drawn	draw	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
indwelling	indwell	VBG	I-NP	O
line	line	NN	I-NP	O
returned	return	VBD	B-VP	O
with	with	IN	B-PP	O
2/4	2/4	CD	B-NP	O
bottles	bottle	NNS	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
gram-positive	gram-positive	JJ	B-NP	B-protein
cocci	coccus	NNS	I-NP	I-protein
in	in	IN	B-PP	O
clusters	cluster	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
central	central	JJ	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
treatment	treatment	NN	B-NP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
gram	gram	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
and	and	CC	I-NP	O
pelvis	pelvis	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
per	per	IN	B-PP	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
recommendation	recommendation	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
intraabdominal	intraabdominal	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
with	with	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
until	until	IN	B-PP	O
4/14/01	4/14/01	CD	B-NP	O
,	,	,	O	O
hospital	hospital	NN	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
visiting	visit	VBG	B-VP	O
nurse	nurse	NN	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
IV	IV	CD	B-NP	O
and	and	CC	O	O
p.o.	p.o.	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
x	x	SYM	O	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
following	follow	VBG	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_line
central	central	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
returned	return	VBD	B-VP	O
as	as	RB	B-PP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
6	6	CD	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
yeast	yeast	NN	I-NP	O
infection	infection	NN	I-NP	O
surrounding	surround	VBG	B-VP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
incision	incision	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intertriginous	intertriginous	JJ	I-NP	O
areas	area	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
topical	topical	JJ	B-NP	B-protein
nystatin	nystatin	NN	I-NP	I-protein
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Routine	Routine	NN	B-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
5/25/01	5/25/01	CD	B-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
per	per	IN	B-PP	O
her	her	PRP$	B-NP	O
transplant	transplant	NN	I-NP	O
protocol	protocol	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
increased	increase	VBD	B-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
of	of	IN	B-PP	O
3.1	3.1	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
decreasing	decrease	VBG	I-VP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Adjustments	Adjustment	NNS	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
in	in	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	O	O
cyclosporin	cyclosporin	NN	B-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
slowly	slowly	RB	B-ADVP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
difficulties	difficulty	NNS	I-NP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	B-protein
function	function	NN	I-NP	I-protein
until	until	IN	B-PP	I-protein
hospital	hospital	NN	B-NP	I-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
5	5	CD	I-NP	I-protein
when	when	WRB	B-ADVP	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
noting	note	VBG	I-VP	O
increasingly	increasingly	RB	B-NP	O
loose	loose	JJ	I-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
diff	diff	NNP	I-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
x	x	NN	B-NP	O
2	2	CD	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Imodium	Imodium	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Rheumatology	Rheumatology	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
initially	initially	RB	B-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
swelling	swell	VBG	B-VP	O
noted	note	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Rheumatology	Rheumatology	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
joint	joint	NN	I-NP	O
was	be	VBD	B-VP	O
tapped	tap	VBN	I-VP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Rheumatology	Rheumatology	NN	B-NP	O
and	and	CC	O	O
,	,	,	O	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
Rheumatology	Rheumatology	NN	B-NP	O
and	and	CC	I-NP	O
Transplant	Transplant	NN	I-NP	O
Team	Team	NN	I-NP	O
recommendations	recommendation	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
colchicine	colchicine	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
on	on	IN	B-PP	O
immunosuppressant	immunosuppressant	JJ	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
plantar	plantar	NN	B-NP	O
fasciitis	fasciitis	NN	I-NP	O
was	be	VBD	B-VP	O
raised	raise	VBN	I-VP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
pain	pain	NN	B-NP	O
medication	medication	NN	I-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
colchicine	colchicine	NN	B-NP	O
and	and	CC	O	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Vancomycin	Vancomycin	NN	B-NP	O
750	750	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
;	;	:	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
x	x	NN	I-NP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
;	;	:	O	O
Percocet	Percocet	NN	B-NP	O
1-2	1-2	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
3-4h	3-4h	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
visiting	visit	VBG	I-NP	O
nurse	nurse	NN	I-NP	O
established	establish	VBN	B-VP	O
for	for	IN	B-PP	O
continued	continue	VBN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
dressing	dress	VBG	B-VP	O
changes	change	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
cyclosporin	cyclosporin	NN	I-NP	O
levels	level	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
team	team	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
her	her	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
and	and	CC	I-NP	O
immunosuppressant	immunosuppressant	JJ	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
routine	routine	JJ	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
team	team	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
appointment	appointment	NN	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
OB/GYN	OB/GYN	NN	B-NP	B-protein
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
'	'	POS	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
RAMON	RAMON	NNP	B-NP	O
ARAKAWA	ARAKAWA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ZW64	ZW64	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WARNER	WARNER	NNP	B-NP	O
J.	J.	NNP	I-NP	O
BURSTON	BURSTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HJ5	HJ5	NNP	I-NP	O
PV049/5050	PV049/5050	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
75859	75859	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

SFODUA63ZE	SFODUA63ZE	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/13/01	10/13/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/30/01	9/30/01	CD	B-NP	O

